CEO transition; Herantis to focus on HER-096
Herantis Pharma Plc, Company Release, inside information, 20 January 2022 at 16:30 EET Herantis Pharma Plc's ("Herantis") Board of Directors has appointed Frans Wuite, MD, MBA, as interim CEO of the company, effective immediately. Wuite is currently Vice Chairman of Herantis' Board of Directors and will continue in this role. Herantis' current CEO, Dr. Craig Cook, leaves the company following the Board of Directors' decision. A search for a permanent CEO will be launched. In connection with the CEO transition and following strong preclinical data in 2021, Herantis' Board of Directors